Velocity raises $38M to build stablecoin treasury infrastructure for enterprises
Stablecoin treasury platform Velocity has raised $38 million in a Series A funding round to expand infrastructure that helps enterprises and financial institutions use stablecoins for cross-border settlement and treasury operations.
The funding round was led by Dragonfly and FirstMark, with participation from Activant Capital, Capital One Ventures, QED Investors, Coinbase Ventures, Wintermute Ventures and Ripple. Velocity said it plans to use the capital to expand its banking and payments network, develop new products and strengthen its regulatory capabilities.
Founded in 2025, Velocity develops software that connects stablecoin networks with banking, custody, compliance and settlement systems. The company targets enterprise finance teams, payment providers, fintech firms and financial institutions using stablecoins for cross-border payments and treasury operations.
The latest financing brings Velocity’s total funding to nearly $50 million since it launched in 2025, according to the company.
Related:
The funding comes as competition in the enterprise stablecoin market intensifies. In June, more than 140 companies backed the launch of Open USD (OUSD), a dollar-pegged stablecoin supported by companies including Visa, Mastercard, Coinbase and Ripple.
Stablecoin infrastructure investment accelerates
Investment in stablecoin infrastructure has accelerated this year as companies build the software and network infrastructure supporting payments, settlement and enterprise financial services.
In March, Tether participated in a $5.2 million funding round for Ark Labs, a startup building infrastructure for stablecoin issuance and settlement on Bitcoin. The company is developing a programmable execution layer to enable faster payments and more complex financial applications on the network.
Later that month, OpenFX raised $94 million in a Series A funding round to expand its stablecoin-based foreign exchange network, which is designed to speed up cross-border payments for businesses. The company said it would use the capital to expand into Southeast Asia and Latin America while increasing liquidity across its network.
Trace Finance secured $32 million the following month to expand its cross-border payment infrastructure, which combines banking, foreign exchange and stablecoin settlement services for businesses operating across multiple markets.
The investments come as stablecoin payments continue to expand. A joint analysis by McKinsey and Artemis Analytics estimated that stablecoins processed $390 billion in annualized real-world payments in 2025, including about $226 billion in business-to-business transactions.
Annualized real-world stablecoin payment volume by use case. Source: McKinsey, Artemis Analytics
Magazine:
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
Crypto prices
More
